| Cognitive impairment and the brain dopaminergic system in Parkinson disease:[18F] fluorodopa positron emission tomographic study JO Rinne, R Portin, H Ruottinen, E Nurmi, J Bergman, M Haaparanta, ... Archives of neurology 57 (4), 470-475, 2000 | 454 | 2000 |
| Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. J Hietala, E Syvälahti, K Vuorio, V Räkköläinen, J Bergman, ... Lancet (London, England) 346 (8983), 1130-1131, 1995 | 430 | 1995 |
| Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. P Nuutila, VA Koivisto, J Knuuti, U Ruotsalainen, M Teräs, M Haaparanta, ... The Journal of clinical investigation 89 (6), 1767-1774, 1992 | 375 | 1992 |
| An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome HM Ruottinen, M Partinen, C Hublin, J Bergman, M Haaparanta, O Solin, ... Neurology 54 (2), 502-502, 2000 | 347 | 2000 |
| Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia J Hietala, E Syvälahti, H Vilkman, K Vuorio, V Räkköläinen, J Bergman, ... Schizophrenia research 35 (1), 41-50, 1999 | 319 | 1999 |
| Gender and insulin sensitivity in the heart and in skeletal muscles: studies using positron emission tomography P Nuutila, MJ Knuuti, M Mäki, H Laine, U Ruotsalainen, M Teräs, ... Diabetes 44 (1), 31-36, 1995 | 288 | 1995 |
| Rate of progression in Parkinson's disease: A 6‐[18F]fluoro‐L‐dopa PET study E Nurmi, HM Ruottinen, J Bergman, M Haaparanta, O Solin, P Sonninen, ... Movement disorders: official journal of the Movement Disorder Society 16 (4 …, 2001 | 254 | 2001 |
| Fluorine-18-labeled fluorine gas for synthesis of tracer molecules J Bergman, O Solin Nuclear medicine and biology 24 (7), 677-683, 1997 | 253 | 1997 |
| Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects A Laakso, H Vilkman, J Örgen Bergman, M Haaparanta, O Solin, ... Biological psychiatry 52 (7), 759-763, 2002 | 232 | 2002 |
| Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose M Lapela, S Leskinen, HR Minn, P Lindholm, PJ Klemi, KO Soderstrom, ... | 230 | 1995 |
| Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant M Bergström, RJ Hargreaves, HD Burns, MR Goldberg, D Sciberras, ... Biological psychiatry 55 (10), 1007-1012, 2004 | 222 | 2004 |
| Positron emission tomography shows that impaired frontal lobe functioning in Parkinson’s disease is related to dopaminergic hypofunction in the caudate nucleus A Brück, R Portin, A Lindell, A Laihinen, J Bergman, M Haaparanta, ... Neuroscience letters 311 (2), 81-84, 2001 | 212 | 2001 |
| The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects A Laakso, T Pohjalainen, J Bergman, J Kajander, M Haaparanta, O Solin, ... Pharmacogenetics and genomics 15 (6), 387-391, 2005 | 211 | 2005 |
| 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer G Komar, M Seppänen, O Eskola, P Lindholm, TJ Grönroos, S Forsback, ... Journal of nuclear medicine 49 (12), 1944-1951, 2008 | 206 | 2008 |
| Radiosynthesis and Evaluation of [18F]Selectfluor bis(triflate) H Teare, EG Robins, A Kirjavainen, S Forsback, G Sandford, O Solin, ... Angewandte Chemie International Edition 49 (38), 6821-6824, 2010 | 203 | 2010 |
| Increased brain fatty acid uptake in metabolic syndrome A Karmi, P Iozzo, A Viljanen, J Hirvonen, BA Fielding, K Virtanen, ... Diabetes 59 (9), 2171-2177, 2010 | 200 | 2010 |
| Catalytic decarboxylative fluorination for the synthesis of tri-and difluoromethyl arenes S Mizuta, ISR Stenhagen, M O’Duill, J Wolstenhulme, AK Kirjavainen, ... Organic letters 15 (11), 2648-2651, 2013 | 199 | 2013 |
| High levels of dopamine activity in the basal ganglia of cigarette smokers RKR Salokangas, H Vilkman, T Ilonen, T Taiminen, J Bergman, ... American Journal of Psychiatry 157 (4), 632-634, 2000 | 199 | 2000 |
| Personality traits and brain dopaminergic function in Parkinson's disease V Kaasinen, E Nurmi, J Bergman, O Eskola, O Solin, P Sonninen, ... Proceedings of the National Academy of Sciences 98 (23), 13272-13277, 2001 | 191 | 2001 |
| Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [18F]CFT E Nurmi, HM Ruottinen, V Kaasinen, J Bergman, M Haaparanta, O Solin, ... Annals of Neurology: Official Journal of the American Neurological …, 2000 | 181 | 2000 |
